The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's Sexual Health Test ...

Last year, the Food and Drug Administration (FDA) approved the first at-home test for three prevalent infections in women – ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...

This at-home, nonprescription STI test has high positive accuracy rates in diagnosing chlamydia, gonorrhea, and trichomoniasis and has been FDA-approved for marketing. HealthDay News — The US Food and ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever testing kit for sexually transmitted infections that can be taken at home without a prescription. But it's not for everyone. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that ...

In a major advancement for women's health, the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the first home-based, nonprescription diagnostic test for three common ...

This cross-sectional study of adults residing in New York City showed discrepancies between testing rates for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and HIV and their ...